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Abstract
Background:  RNA amplification is required for incorporating laser-capture microdissection
techniques into microarray assays. However, standard oligonucleotide microarrays contain sense-
strand probes, so traditional T7 amplification schemes producing anti-sense RNA are not
appropriate for hybridization when combined with conventional reverse transcription labeling
methods. We wished to assess the accuracy of a new sense-strand RNA amplification method by
comparing ratios between two samples using quantitative real-time PCR (qPCR), mimicking a two-
color microarray assay.
Results: We performed our validation using qPCR. Three samples of rat brain RNA and three
samples of rat liver RNA were amplified using several kits (Ambion messageAmp, NuGen Ovation,
and several versions of Genisphere SenseAmp). Results were assessed by comparing the liver/brain
ratio for 192 mRNAs before and after amplification. In general, all kits produced strong correlations
with unamplified RNAs. The SenseAmp kit produced the highest correlation, and was also able to
amplify a partially degraded sample accurately.
Conclusion: We have validated an optimized sense-strand RNA amplification method for use in
comparative studies such as two-color microarrays.
Background
One of the principal complications in microarray analysis
of gene expression is the relatively large amount of input
RNA required for each assay. On average, 1–20 µg of total
RNA are required per study using glass microarrays [1-4].
This is easily obtained from standard tissue samples, but
is more difficult to obtain from smaller samples, such as
laser capture microdissections [5,6]. The primary impedi-
ment to the use of laser capture microscopy (LCM) in gene
expression analysis is that microdissections yield insuffi-
cient mRNA due to low total RNA recovered from small
sample sizes. With samples such as these, the ability to
conduct a linear amplification of the target mRNA
becomes imperative, to ensure that enough material is
available for gene expression analysis. There are several
methods for amplifying RNA including the arithmetic
transcription methods [7,8], PCR based exponential
amplification, or a combination of both arithmetic and
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exponential amplification [9]. Each method has proven
effective in generating large amounts of amplified RNA
from small starting samples. Each method is not without
its drawbacks however. PCR based amplification has been
shown to amplify sequence-dependent biases geometri-
cally, and hybridization kinetics during the thermal cycles
can create sequence-dependent and abundance-depend-
ant biases [10]. New methods must be carefully validated
with large numbers of mRNAs before they may be
accepted for general use.
Most RNA amplification methods are based on the T7-
based antisense RNA amplification technique first
described by Van Gelder and Eberwine in 1990 [7]. In this
technique poly(A)+ mRNA is reverse-transcribed and con-
verted into double stranded cDNA using an oligo(dT)
primer containing a promoter for T7 RNA polymerase.
The second strand cDNA serves as a transcription template
for amplified antisense RNA (aRNA) production. cDNA
microarray studies using T7 amplified RNA have shown
that the technique yields reproducible results that corre-
late with the results obtained from using total RNA
[2,9,11]. This method is incompatible, however, with
standard spotted oligonucleotide microarrays when com-
bined with conventional reverse transcription based labe-
ling methods.
Spotted oligo microarrays consist of 'long' 50–80 mer
sense-strand oligonucleotide probes arrayed onto a suita-
ble substrate. Each probe sequence is designed to hybrid-
ize to a specific antisense cDNA reverse transcribed from a
given mRNA species. The advantage of spotted oligo
microarrays over cDNA microarrays is that the oligos can
be designed to be more specific, with similar hybridiza-
tion kinetics, lower homology among related transcript
probes, and selection among different splice variants of
the same gene. However, aRNA prepared from Eberwine-
amplified mRNA would produce a sense-strand cDNA tar-
get that would not hybridize with sense-strand oligo
probes on the microarray.
The Genisphere SenseAmp linear mRNA amplification
method produces sense-strand amplified mRNA by incor-
porating a double stranded T7 promoter into the 3' end of
the first strand cDNA, driving transcription of an ampli-
fied RNA with the same strandedness as mRNA. Sen-
seAmp linear amplification also allows for the use of dT
and random primers in the synthesis of cDNA. This varia-
tion on the amplification protocol may be as effective on
partially degraded mRNA or, using random primers in a
first-strand reaction, on RNAs lacking a poly(A) tail. Fur-
ther, the use of random primers combined with dT prim-
ing may help to reduce the 3' bias associated with
Eberwine-based amplification methods [12,13] by
improving the access of reverse transcription to the 5' end
of mRNA.
Most studies evaluating amplification validity compare
unamplified to amplified material [3,14-17]. However,
this is not a good model of experiments normally per-
formed with spotted oligo microarrays. In most two-color
microarray experiments, an experimental sample is com-
pared with a reference sample on the same microarray, so
it is the ratio between two samples that becomes the most
important parameter. RNA amplification may have some
sequence bias, but as long as the bias is consistent
between reactions, the effect of the bias may be canceled.
We chose, therefore, to evaluate amplification strategies
by comparing two RNA samples both before and after
amplification, and correlating the ratios obtained before
and after amplification. This key difference allows us to
identify the best amplification method for use with two-
color microarrays.
Throughout the course of this study, several pre-produc-
tion versions of SenseAmp were evaluated with the aim of
judging the optimal method. Total RNA from replicate rat
brain and liver samples was amplified using one of several
different techniques including three versions of the Sen-
seAmp method, MessageAmp from Ambion, Nugen's
Ovation RNA-based single primer isothermal amplifica-
tion (Ribo-SPIA) method, and as an additional study,
SenseAmp amplification of partially degraded RNA sam-
ples. The ratio of amplified RNAs obtained from each
method was compared via relative qPCR to that of unam-
plified mRNAs from the same pool to determine how
accurately the relative abundances were preserved. The use
of qPCR provides a much broader range of results than
possible with microarrays [18]. Relative qPCR analysis
also allowed for the quantification of amplified RNA
regardless of which strand was amplified, thus a direct
comparison could be made between the various amplifi-
cation techniques.
The fidelity of the amplification methods was determined
using the ∆∆Ct relative quantification method for qPCR.
This method is used to compare the expression of a given
gene in one sample relative to a second, and is based on
the amplification efficiency of the PCR primer pairs used
[19]. Quantitative PCR was selected because of its univer-
sal use as a microarray validation method [10,11,18-21],
enhanced dynamic range [18-20], and ease of use with
limited sample sizes for evaluating expression changes for
several hundred genes. The basis of this method is the
assumption that the exponential amplification of the
starting product, and therefore the amount of PCR prod-
ucts produced with each round of amplification, is
dependent upon the efficiency of each PCR primer pair.
This efficiency is determined either experimentally or isBMC Genomics 2004, 5:76 http://www.biomedcentral.com/1471-2164/5/76
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calculated from the raw fluorescence data obtained during
the qPCR amplification [22]. Equation (1) was used to
compare the expression of 192 different genes in rat liver
and rat brain samples. Triplicate total RNA samples from
rat brain and liver were analyzed for each pair of primers
targeting the mRNA concentrations of a given gene.
Ratio of gene expression = E-∆∆Ct   (1)
Through comparison of the relative gene expression
across the various different amplification techniques, we
were able to determine that each amplification method
produces amplified RNA in quantities that accurately
reflect the original mRNA proportions. The SenseAmp kit
exhibited the best correlation to the unamplified control,
and was effective in amplifying degraded RNA samples as
well. In addition, we inadvertently identified a potential
bias that can arise with the use of the oligo dT in reverse
transcription priming.
Distributions of liver/brain RQ ratios for all amplification methods Figure 1
Distributions of liver/brain RQ ratios for all amplification methods. Box and whiskers plot showing the distribution of log2 RQ 
ratios for each amplification method. The blue diamond is centered on the mean and shows the 95% CI of the mean. The blue 
lines depict the percentile range. The center of the notched box is the median, with the notches showing the 95% CI of the 
median. The boxes show the inter-quartile range (IQR). Dashed lines are 1.5 times the IQR. Outliers are shown as red crosses 
(1.5–3.0 times the IQR) or red circles (>3.0 times the IQR).
Table 1: Correlations between liver/brain RQ ratios of amplified vs. unamplified RNAs. For each correlation, n is the number of PCR 
results retained after filtering the amplification efficiency [22]. The correlation coefficient (r) is shown along with its 95% confidence 
interval (CI). Each correlation was significant at p < 0.0001. A cross-correlation matrix showing all relationships between samples is 
available at http://cord.rutgers.edu/amplification/index.html
n* r‡ 95% CI p
MessageAmp™ 121 0.80 0.74 To 0.85 <0.0001
Ovation™ 112 0.82 0.76 To 0.86 <0.0001
SenseAmp™ Version 1 118 0.87 0.83 To 0.90 <0.0001
SenseAmp™ Version 2 121 0.88 0.85 To 0.91 <0.0001
SenseAmp™ Version 1–2 121 0.90 0.87 To 0.93 <0.0001
2 Rounds Version 1–2 121 0.89 0.85 To 0.92 <0.0001
SenseAmp™ on degraded RNA 121 0.94 0.92 To 0.96 <0.0001
* number of valid samples shared with unamplified control
‡Pearson correlation coefficient
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Results
We compared liver/brain expression ratios for a broad col-
lection (n = 192) of mRNAs before and after amplifica-
tion. Rat brain and liver RNAs were chosen since we
needed to begin with large quantities of unamplified
materials in order to test several amplification reactions
on the same starting material, and to reliably assay the
unamplified RNA. Several variations on the amplification
method were tested to determine which method best rep-
licated the distribution of liver/brain ratios found in
unamplified RNAs. As anticipated, each of the amplifica-
tion techniques produced amplified RNA that reproduced
the full range of relative quantities (RQ) between liver and
brain RNAs (Figure 1) and correlated well with the initial
mRNA pool (Table 1, Figure 2). The SenseAmp version 1–
2, which was designed to incorporate aspects of both ver-
sion 1 and version 2, was shown to be most similar to the
unamplified control results with a correlation coefficient
of 0.90. As indicated by the lack of overlap in the 95%
confidence intervals, SenseAmp version 1–2 produced
amplified RNA with greater fidelity than either the Mes-
sageAmp or Ovation methods. Furthermore, each succes-
sive version of the SenseAmp protocol appeared to
enhance the fidelity of the result. A series of two rounds of
amplification with SenseAmp version 1–2 was indistin-
guishable in correlation to the unamplified control from
a single round. These results suggest that each amplifica-
tion technique is capable of producing linearly-amplified
RNA that represents the relationships of the two original
tissues. The SenseAmp kit (version 1–2) produced the
most accurate reproduction of the original liver/brain
ratios while also providing a sense-strand amplified RNA
appropriate for use with oligonucleotide microarrays.
Amplification of partially-degraded RNA samples using
the SenseAmp version 1–2 method also produced a high
correlation of liver/brain ratios to those from unamplified
RNAs (r = 0.94). This high correlation using degraded
RNA appeared to be due to the presence of random primer
in the amplification reaction. Comparing the rank order
of mRNA abundances in liver (Table 2), we found that
reactions using oligo dT primers generally produced
higher correlations between amplified RNAs indicating
that a similar offset to the rank order was occurring for all
dT based methods. However comparing the dT primer
rank order to that of random primed samples demon-
strates greater dissimilarity, although this effect was varia-
ble. We interpret these results as supporting the
hypothesis that the addition of a random primer to the
amplification assay inadvertently enhances the correla-
tion to random-primed, unamplified RNA, partially off-
setting the negative effect of RNA degradation.
Discussion
Most studies of the fidelity of amplified RNA have com-
pared the amplified sample to the original total RNA sam-
ple exclusively [2-4,10,14]. While this is valid, the
approach described here more accurately reproduces the
standard experimental conditions for two-color microar-
ray expression analysis by comparing the ratio of gene
expression between two different samples. The ratios
obtained for amplified brain RNA vs. amplified liver RNA
are then compared to the ratios from the unamplified
control comparison (Table 1, Figure 2). Any reproducible
biases within the techniques are represented in both the
brain and liver samples and therefore cancelled out in the
comparison. This approach models a two-color gene
expression comparison experiment and demonstrates the
differences in expression profiles obtained from different
amplification techniques.
Using this approach, all three amplification kits tested
had correlation coefficients of 0.80 or greater, indicating a
great deal of fidelity in amplifying paired samples of RNA.
The SenseAmp kit performed relatively better among the
three, with a correlation coefficient of 0.90, with the 95%
confidence interval lying above the means and intervals
produced with MessageAmp or Ovation methods. Other
researchers have shown that additional rounds of amplifi-
cation yield reproducible results for a single RNA sample
with only modest biases [6,10]. The fidelity of amplifica-
tion was maintained in the course of our experiments
with the SenseAmp production kit, through a second
round of amplification. The similar correlations between
the SenseAmp version 1–2 and the two rounds of version
1–2 amplification indicate that a second round of ampli-
fication does not significantly affect the relative abun-
dance of mRNA. Of the three SenseAmp versions tested,
version 1–2 had the highest correlation to unamplified
RNA using this approach. In order to confirm that qPCR
was an appropriate choice for validating RNA amplifica-
tion procedures, we compared the brain vs. liver expres-
sion ratios on oligonucleotide arrays of SenseAmp version
1–2 amplified to unamplified RNA (not shown). As we
observed with qPCR, a high correlation of about 0.93 was
observed after comparing about 2700 differentially
expressed genes, indicating that our qPCR experimental
design was appropriate.
Variations in correlation among the versions of the Sen-
seAmp method may be due to modifications to the struc-
ture of the T7 promoter/cDNA template. The version 1
template consisted of a completely double stranded linear
DNA molecule, with one strand of the promoter
synthesized enzymatically. For version 2, the T7 promoter
was composed of two prehybridized, synthetic DNA
strands ligated to a single stranded cDNA template. For
version 1–2, a double stranded T7 promoter wasBMC Genomics 2004, 5:76 http://www.biomedcentral.com/1471-2164/5/76
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synthesized onto the end of a single stranded cDNA tem-
plate from a T7 template oligo by a 3' recessed end "fill-
in" reaction using the Klenow fragment of DNA polymer-
ase I. Like version 1, the promoter contains one enzymat-
ically-synthesized strand and like version 2 the cDNA
portion is single stranded. The incorporation of an enzy-
matically-synthesized strand appears be a more effective
initiation site for the T7 polymerase (unpublished
results). Furthermore, single stranded DNA templates
downstream of the ds T7 promoter have been shown to be
very efficient T7 polymerase templates [23,24] demon-
strating a 2 fold improvement in kinetics [24]. The com-
bined increase in T7 amplification efficiency in version 1–
2 may preserve the distribution of mRNA concentrations
in the amplified product.
Previous studies have cautioned against comparing sam-
ples using different reverse transcription primers [2].
Scatterplots comparing liver/brain log2 RQ ratios of amplified RNAs with unamplified RNA Figure 2
Scatterplots comparing liver/brain log2 RQ ratios of amplified RNAs with unamplified RNA. For each amplification method, a 
scatter plot shows the correlation of the liver/brain ratio to that of unamplified RNA. A linear regression fit is plotted as a line 
with the equation shown. The coefficient of determination (R2) corresponds to the square of the correlation coefficient (r) in 
Table 1.
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Priming with oligo dT reduced PCR yields and created 3'
and sequence-specific biases compared with the use of
random primer [13,14,25]. These biases arise from the
specificity shown by oligo dT primer for the 3' poly(A) tail
and low processivity of T7 polymerase, as well as the pres-
ence of internal poly(A) sequences which may act as
additional priming sites for the oligo dT. Random primer
has also been shown to create a better 3'/5' ratio than the
oligo dT primer [14].
Our experimental design called for the use of oligo dT
primer in most of the RNA amplification reactions but
random primer in the cDNA synthesis phase of qPCR.
This design was used for each of the comparison experi-
ments and therefore any bias introduced by the oligo dT
primed reaction would be repeated for each of the ampli-
fication techniques. The effect of the oligo dT priming in
the RNA amplification was identified when the degraded
RNA sample was amplified using a mixture of oligo dT
primer and random primer. The result showed that the
degraded sample amplification resulted in a higher corre-
lation to the unamplified control than any of the amplifi-
cation techniques including the SenseAmp amplification
of intact RNA. It is our interpretation that this high corre-
lation of the amplified, degraded samples to the unampli-
fied qPCR samples may be due to the common use of
random primers for both data sets.
Conclusions
Overcoming the problem of tissue heterogeneity with
LCM and other, similar techniques will allow the research
community to focus its efforts on the biologically relevant
cell types. The use of RNA amplification with these small,
cell-type specific techniques provides reliable and repro-
ducible quantities of mRNA suitable for high-throughput
gene expression profiling. Amplification from small
amounts of LCM-selected samples provides stronger
hybridization signal and reduced biological noise attrib-
uted to the presence of other cell types.
RNA amplification has been shown here, and elsewhere,
to be both a useful and consistent technique for produc-
tion of practical amounts of RNA when limited starting
material is available. While there are several reliable
amplification methods available, most amplify an anti-
sense RNA which is suitable for cDNA microarray analy-
sis. The most apparent benefit of the SenseAmp method is
the amplification of the sense mRNA strand. This allows
for the direct use of cDNA reverse-transcribed from ampli-
fied RNA as a hybridization target for oligo microarrays,
and any other analysis that requires a sense-strand orien-
tation. In addition, we observed similar liver/brain ratios
between amplified RNAs and unamplified RNAs. This
comparison models the relative expression ratios
observed with two-color microarrays. While each of the
methods tested produced acceptable results, the Sen-
seAmp methods provided optimal correlation between
unamplified samples and sense-strand amplified RNA.
Methods
Primer design
A subset of 192 sequence targets was chosen from the
Compugen/Sigma-Genosys Rat 8 K oligo library for qPCR
analysis. Using previously-analyzed microarray results as
a guide (not shown), we selected targets with a broad
range of expression ratios from brain-specific, through
common, to liver-specific mRNAs. GAPDH mRNA was
also selected for normalization. Primers were designed for
all 193 sequences using Applied Biosystems Primer
Express software v2.0 (Applied Biosystems, Foster City,
CA). Primers were designed to have a Tm between 58°C
and 60°C and with an optimal length of 20 nt. The %GC
content was held between 20% and 80% with no 3' GC
clamp. The target amplicon for each sequence was
designed to be between 50 and 150 nt with an optimal Tm
Table 2: Rank correlations of liver Ct values identifies effects of oligo d(T) primers vs. random hexamer primers.
Unamplified MessageAmp NuGen Version 1 Version 2 Version 1–2 2 Rounds V 1–2
MessageAmp 0.75 1
NuGen 0.65 0.83 1
Version 1 0.61 0.68 0.61 1
Version 2 0.84 0.92 0.78 0.71 1
Version 1–2 0.84 0.90 0.84 0.67 0.95 1
2 Rounds V1–2 0.79 0.89 0.81 0.67 0.93 0.92 1
Degraded V1–2 0.85 0.85 0.77 0.71 0.89 0.91 0.85
Rank cross-correlation matrix for liver Ct values. The mean cycle threshold (Ct) values obtained with liver RNA samples were rank-ordered and 
correlated. Results indicate the faithful reproduction of an ordered list of mRNA concentrations in liver RNA before and after amplification. Results 
were filtered for acceptable PCR efficiencies (see Methods), producing 138 primer pairs for this analysis. Methods using random primer (including 
unamplified RNA) are bold, those using oligo d(T) are italicized. Scatter plots of each rank Ct correlation are available at: http://cord.rutgers.edu/
amplification/index.htmlBMC Genomics 2004, 5:76 http://www.biomedcentral.com/1471-2164/5/76
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of 85°C. The target mRNAs represented a broad range of
sizes (as measured by cDNA lengths; range 110–8074;
mean 1876 nt; 190 nt 95% CI) and base composition
(range 38–68% GC; mean 52% GC; 0.85% 95% CI).
Amplicons were distributed between 5'UTR (8.7%), cod-
ing sequence (82.0%), and 3'UTR (9.2%). Primers were
purchased from Sigma-Genosys (The Woodlands, TX).
The final working concentration for each of the primer
pairs was 50 nM. A table of target sequences and primers
is available in the supplemental materials http://cord.rut
gers.edu/amplification/index.html.
Preparation of total RNA
Samples of rat brain (n = 3) and rat liver (n = 3) were fro-
zen in liquid nitrogen and ground to a coarse powder.
RNA was isolated from each sample using TRIzol (Invitro-
gen, Carlsbad CA). After isolation, samples of the pre-
pared RNA were further purified using a Qiagen RNeasy
column (Qiagen, Valencia CA). Total RNA was quantified
by UV spectrophotometry and the integrity was assessed
using a Bioanalyzer model 2100 (Agilent, Palo Alto CA).
Identical total RNA samples were divided among the 8 dif-
ferent experiments (including unamplified control).
Degraded RNA was prepared by treatment at 65°C for 15
minutes in fragmentation buffer (40 mM Tris acetate, pH
8.1, 100 mM potassium acetate, 30 mM magnesium ace-
tate). Samples of RNA degraded under these conditions
were analyzed on an Agilent Bioanalyzer using RNA Nano
chips and 2100 Expert software. Degraded samples typi-
cally had little or no 28S rRNA peak remaining and a
broad smear below a weaker 18S rRNA peak, correspond-
ing to an RNA Integrity Number (RIN) of 4.9 (using base-
line correction) out of a score of 10 for RNA of ideal
quality.
RNA amplification
Each of the three replicates for each tissue was amplified
using the Ambion messageAmp (Ambion, Austin TX),
NuGen Ovation AminoAllyl amplification (NuGen Tech-
nologies, San Carlos CA), or SenseAmp version 1,
version2, or version 1–2 kits. SenseAmp, version 1–2, is
the commercial version of the Genisphere SenseAmp kit.
Amplification with each method was done according to
the protocol outlined for each method. For each of the
MessageAmp and SenseAmp amplifications, 0.75 µg of
input total RNA was used. For SenseAmp with random
priming, 250 ng of input total RNA was used. The final
yield of amplified RNA for each method was ~36 µg. For
the NuGen Ovation amplification, 70 ng of input total
RNA was used to yield ~10 µg of amplified cDNA.
For all versions of SenseAmp, total RNA was reverse tran-
scribed using 100 ng of an anchored dT primer [d(T)24V]
as described in the SenseAmp manual http://www.geni
sphere.com/rna_amp_protocols.html. For the degraded
RNA samples, random 9 mers were added to the reverse
transcription reaction at twice the mass of the input total
RNA (e.g. 500 ng random primers per 250 ng of total
RNA). Superscript II (Invitrogen) was used for all reverse
transcriptions. The cDNA was purified using a MinElute
PCR Purification Kit (Qiagen).
SenseAmp version 1
The purified cDNA was 3' tailed with dATP. A T7-pro-
moter/oligo d(T) primer was used to initiate second
strand cDNA synthesis using E. coli DNA polymerase I
(Invitrogen) at 16°C for 2 hours as described by the man-
ufacturer. Double-stranded cDNA was purified using the
MinElute PCR Purification Kit and used for in vitro tran-
scription using the MegaScript kit (Ambion). Amplified
sense RNA was purified using the RNeasy Kit (Qiagen)
and the manufacturer's recommendation for RNA clean
up.
SenseAmp version 2
The purified cDNA was poly d(T) tailed as described in the
SenseAmp (Genisphere) product manual. Excess double-
stranded T7-promoter was ligated to the 3' poly d(T) tail
on the cDNA in 1X ligation buffer (Roche) at room tem-
perature for 30 minutes. The double stranded (ds)T7 pro-
moter consisted of equal molar amounts of a T7 promoter
oligo hybridized to a complementary oligo have a 10 base
d(A)10 overhang on the 3' end prehybridized in 6X liga-
tion buffer (Roche Applied Science, Indianapolis IN).
Excess unligated ds T7 promoter was removed using the
MinElute PCR Purification Kit. The purified cDNA, which
contained a double-stranded T7 promoter linked to a sin-
gle stranded cDNA template [23,24], was used for in vitro
transcription using the MegaScript kit (Ambion). Ampli-
fied sense RNA was purified using the RNeasy Kit
(Qiagen).
SenseAmp version 1–2
The complete process is described in the Gensiphere Sen-
seAmp product manual. Briefly, the purified cDNA was
poly d(T) tailed. A T7-promoter/oligo dA template strand
with a 3' blocking group was hybridized to the poly d(T)
tail of the purified cDNA. Double-stranded T7-promoter
was synthesized at room temperature for 30 minutes
using Klenow fragment of DNA Polymerase I
(Invitrogen). The 3' blocker was used to prevent the syn-
thesis of complete second strand cDNA during the T7 pro-
moter "fill-in" reaction. Excess T7 promoter template was
removed using the MinElute PCR Purification Kit. The
purified cDNA, which contained a double-stranded T7
promoter linked to a single stranded cDNA template, was
used for in vitro transcription using the MegaScript kit
(Ambion). Amplified sense RNA was purified using theBMC Genomics 2004, 5:76 http://www.biomedcentral.com/1471-2164/5/76
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RNeasy Kit (Qiagen) and the manufacturer's recommen-
dation for RNA clean up.
cDNA synthesis
Five µg of each amplified RNA sample and unamplified
control (with the exception of the NuGen Ovation ampli-
fication which yielded cDNA directly) was reverse tran-
scribed into cDNA. RNA was added to 1 µl of 50 ng/µl
random hexamer primer, 1 µl 10 mM dNTP mix (Sigma,
St. Louis MO), and RNase-free water to make 12 µl. The
mixture was denatured at 65°C for 5 min and immedi-
ately chilled. Reaction buffer and SuperScript II (Invitro-
gen) was then added and the volume was adjusted to 20
µl. The mixture was then incubated at 25°C for 10 min-
utes, 42°C for 50 minutes, and finally 70°C for 15 min-
utes to stop the reaction.
Quantitative real-time PCR (qPCR)
Each treatment assay was conducted across a total of four
384-well plates per assay. Each plate targeted 48 different
genes for PCR amplification, each with 3 brain and 3 liver
samples as well as 6 GAPDH wells for normalization
across plates. A calibrator plate was used for each treat-
ment to determine the concentration of cDNA required
from each amplification technique to produce a GAPDH
Ct comparable to that derived from the 1:10 dilution in
the unamplified control. cDNAs for the NuGen, 2 rounds
of SenseAmp version 1–2, and SenseAmp version 1–2 on
degraded RNA were all diluted 100X. cDNAs from Sen-
seAmp version 1 were diluted 120X. The remaining ver-
sion 2, version 1–2, and messageAmp cDNA samples were
diluted 200X. 2 µl of diluted cDNA was added to the
primer pair mix and SYBR Green Master Mix (Applied Bio-
systems) in each well. qPCR was conducted on the Prism
7900HT Sequence Detection System (Applied Biosys-
tems). Plates were run for 40 cycles and fluorescence
intensity measured after every cycle. For each target
sequence the average cycle number at which fluorescence
was detected above background in the exponential phase
of amplification was obtained for the brain and liver sam-
ples. This value, Ct, or cycle number at threshold, was used
for calculations of relative abundance of mRNA molecules
in the liver samples compared to the brain samples for
each of the amplification methods.
PCR primer efficiency
The efficiency of each of the 192 target gene PCR primer
pairs was calculated using the LinRegPCR software [22].
Normalized fluorescence values for each well were
recorded for each cycle of RT-PCR. LinRegPCR used the
log of these data to calculate the linear regression of a
"window of linearity" in the exponential phase of ampli-
fication. The efficiency of the primer pairs corresponds to
10slope of the linear regression of the normalized log fluo-
rescence values within the "window of linearity" for each
well. As per the recommendations for this calculation,
PCR primer pairs with strongly deviating PCR efficiencies
or correlation coefficients below 0.999 were discarded
[22] Average efficiency values for each primer pair were
determined and used in equation (1) to reveal the relative
abundance of mRNA in each sample.
Data analysis
The following algorithm was applied to the results from
each amplification method as well as the unamplified
control. As per the ∆∆Ct qPCR analysis method, an aver-
age cycle number was determined at which fluorescence
crossed a threshold above background. The resulting Ct
value was recorded for each tissue type and target gene.
This Ct value was normalized across plates by subtraction
of the Ct value from the housekeeping gene GAPDH. This
value represents the ∆Ct. The ∆Ct from the reference brain
samples was subtracted from the ∆Ct obtained from the
liver samples. This gave the change in ∆Ct between the two
tissues or ∆∆Ct. With the addition of calculated primer
pair efficiencies, the ratio of gene expression for each tar-
get mRNA sequence between the two tissues was deter-
mined using equation (1). Ratios of expression values for
liver tissues relative to brain (RQ) for each amplification
technique were plotted in Excel (Microsoft, Redmond
WA) and Pearson correlations to the unamplified control
were determined using Analyze-It (Analyse-It Software,
http://www.analyse-it.com), an Excel Statistics Add-on.
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